MEDIMonday, 27 March 2006

1:30 PM-4:50 PM Georgia World Congress Center -- Georgia Ballroom 3, Oral
Emerging Small Molecule Therapies for Cardiovascular Disease
Organizers:Jeff Gray
Kevin Peters
1:30 PMCoronary artery disease risk factors: Successes, failures and future directions
Kevin G. Peters
2:10 PMDiscovery of orally bioavailable, non-steroidal mineralocorticoid receptor antagonists: A tale of three platforms
P. K. Jadhav, Donald P. Matthews, Jonathan Green, Kevin Fales, Kostas Gavardinas, Douglas Gernert, Michael G. Bell, David A Neel, Peter S. Lander, Timothy A. Grese, Anthony G Borel, Chen Zhang, Sally Kelley, Karen Zimmermann, Mitchell I. Steinberg
2:50 PMSynthesis and structure activity relationship of potent, selective piperidine-based PPARα agonists
Cheryl M Hayward, Scott W. Bagley, William A. Hada, Ernest S. Hamanaka, Charles Aldinger, Bruce Auerbach, Omar L. Francone, Mehrdad Haghpassand, Christopher D. Kane, H. James Harwood Jr., Lori Royer, Kimberly Stevens, Janice D. Wagner
3:30 PMStructure activity relationship of quinolyl-ureas as Urotensin-II receptor antagonists: The discovery of palosuran
Jörg Velker, Hamed Aissaoui, Christoph Binkert, Magdalena Birker-Robaczewska, Céline Boukhadra, Daniel Bur, Martine Clozel, Walter Fischli, Patrick Hess, Boris Mathys, Keith Morrison, Claus Müller, Oliver Nayler, Alexander Treiber, Michael W. Scherz, Thomas Weller
4:10 PMPathway selective modulators in the elucidation of anti-atherosclerotic effects of LXR
William J. Zuercher

Symposium Grid -- Division of Medicinal Chemistry -- Session Listing

Symposium Grid -- Drug Discovery -- Session Listing

The 231st ACS National Meeting, Atlanta, GA, March 26-30, 2006